NCT01197118 Postoperative Sequence Chemoradiotherapy Compared With Chemotherapy Alone for Advanced Gastric Cancer Status UNKNOWN Phase PHASE2
NCT01191697 CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer Status COMPLETED Phase PHASE2
NCT01180166 Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer Status UNKNOWN Phase PHASE2
NCT01178775 Development and Validation of Perceived Fatigue Meaning Scale on Walking Program Status UNKNOWN Phase NA
NCT01172028 Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01171924 A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors Status COMPLETED Phase PHASE1
NCT01170663 A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma Status COMPLETED Phase PHASE3
NCT01167049 Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis Status UNKNOWN Phase PHASE2
NCT01160419 Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric Cancer Status UNKNOWN Phase PHASE2
NCT01157598 Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation During Endoscopic Submucosal Dissection Status UNKNOWN Phase PHASE3
NCT01147991 Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer Status COMPLETED Phase PHASE1
NCT01138904 FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC) Status COMPLETED Phase PHASE2
NCT01132755 Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage Status COMPLETED Phase PHASE2
NCT01132534 A Randomized Study Comparing Autofluorescence Imaging(AFI) Followed by Narrow Band Imaging(NBI) With Videoendoscopy for the Detection of High Risk Lesions of Stomach Status COMPLETED Phase N/A
NCT01130337 A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer Status COMPLETED Phase PHASE2